The UK Medicines and Healthcare products Regulatory Agency (MHRA) has introduced...
Sanofi will commence a Phase I/II trial with its vaccine candidate in the next f...
While Cassava is stopping investigations into simufilam in Alzheimer’s disease, ...
Character Biosciences has raised $93m in an oversubscribed Series B funding roun...
MSD has entered an exclusive licence agreement with Hengrui Pharma for the oral ...
MSD has received approval from the EC for Capvaxive, a pneumococcal 21-valent co...
EU member states are set to launch the EU Health Data Space Regulation for harmo...
Ensuring the highest standards in pharmaceutical logistics is crucial for patien...
The FDA has approved GSK’s Blujepa for treating uncomplicated urinary tract infe...
Multinational companies in China’s vaccine market face headwinds amid an anti-co...
Valneva will work with local health authorities and wholesalers on the French is...
The government of Alberta has announced a collaboration with Siemens Healthineer...
Today marks World TB Day 2025 with the WHO calling for more investment into TB t...
Augustine Therapeutics has raised €78m ($85m) in funding to support the developm...
The FDA has granted approval for the IND application of Everest Medicines’ tumou...
AstraZeneca has announced a $2.5bn investment to establish the company’s sixth w...
